Market Report Service
Home About Us Industry Report Store Resources Contact us

Embolotherapy Market Reaches US$ 7.37 Billion by 2030

Embolotherapy Market Growth Analysis Report by Product (Embolic Agents (Microspheres, Embolic Coils Liquid Embolic Agents, Embolic Plug Systems, and Detachable Balloons), Support Devices (Microcatheters and Guidewires)), Procedure (Transcatheter Arterial Embolization (TAE), Selective Internal Radiation Therapy (SIRT), and Trans Arterial Chemoembolization (TACE)), End-User (Hospitals, Clinics, and Ambulatory Surgery Centers), and by Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa) Global Trends and Forecast from 2023 to 2030

5/5
( 20 votes )

Categories: Pharma & Healthcare

Format : Embolotherapy Market Reaches US$ 7.37 Billion by 2030

1.Summary

1.1. Embolotherapy Market Overview

1.2. Key Insights

1.3. Report Scope

1.4. Research Methodology

1.5. Frequently Asked Questions

1.6. Chapter Outlines

  1. Decision-Making Summary
  2. Introduction

3.1. Overview Of Embolotherapy

3.2. Key Historical Events

3.3. Structure

3.4. Biochemical Interaction

3.5. Target Indications

3.6. Advantages Of Embolotherapy

3.7 Challenges Associated With Embolotherapy

3.8. Future Perspectives.

  1. Market Landscape

4.1. Methodology

4.2 Embolotherapy: Developer Landscape

4.2.1. Analysis by Year Of Establishment

4.2.2. Analysis By Company Size

4.2.3. Analysis By Location Of Headquarters (Region-Wise)

4.2.4. Analysis By Location Of Headquarters (Country-Wise)

4.2.5. Analysis By Year Of Establishment, Company Size And Location Of Headquarters (Region-Wise)

4.2.6. Most Active Players

  1. Company

5.1. Company Overview

5.1.2 Management Team

5.1.3. Product Portfolio

5.1.4. Recent Developments And Future Outlook

  1. Partnerships And Collaborations

6.1. Partnership Models

6.2. Embolotherapy: Partnerships And Collaborations

6.2.1. Analysis By Year Of Partnership

6.2.2. Analysis By Type Of Partnership

6.2.3. Analysis By Year And Type Of Partnership

6.2.4. Analysis By Type Of Partner

6.2.5. Analysis by Year Of Partnership And Type Of Partner

6.2.6. Analysis By Type Of Partnership And Type Of Partner

6.2.7. Analysis By Type Of Partner And Parent Company Size

  1. Academic Grants Analysis

7.1. Methodology And Key Parameters

7.2. Embolotherapy: Academic Grants Analysis

7.2.1. Analysis By Year Of Grant Award

7.2.2. Analysis By Amount Awarded

7.2.3. Analysis By Funding Institute Center

7.2.4. Analysis By Support Period

7.2.5. Analysis By Funding Institute Center And Support Period

7.2.6. Analysis by Type Of Grant Application

7.2.7. Analysis By Purpose Of Grant

  1. Publication Analysis

8.1. Analysis Methodology And Key Parameters

8.2. Embolotherapy: Publication Analysis

8.2.1. Analysis by Year Of Publication

8.2.2. Analysis By Type Of Publication

8.2.3. Analysis by Type Of Conjugate

8.2.4. Analysis by Target Indication

8.2.5. Analysis by Copyright Holder

8.2.6. Word Cloud: Emerging Focus Area

8.2.7. Most Active Publishers: Analysis By Number Of Publications

  1. Success Protocol Analysis

9.1. Methodology and Key Parameters

9.2. Key Assumptions and Scoring Criteria

9.3. Success Protocol Analysis

9.4. Assessment of Approved Embolotherapy

  1. Appendix 1: Tabulated Data
  2. Appendix 2: List Of Companies 
  1. Boston Scientific Corporation
  2. Cook Medical
  3. Guerbet
  4. Imbiotechnologies Ltd.
  5. Johnson & Johnson
  6. Kaneka Corporation
  7. Medtronic
  8. Meril Life Sciences Pvt. Ltd.
  9. Merit Medical Systems
  10. Penumbra
  11. Simbionix USA Corporation
  12. Sirtex Medical Limited
  13. Stryker Corporation

Select Licence Type


Single User

US$ 2499


Multi User

US$ 3499


Corporate User

US$ 4499

Only one user can access the report. It cannot be printed or shared. Delivery in online PDF.

US $ 2499

Multiple users can access the report. It cannot be printed or shared. Delivery in online PDF.

US $ 3499

The entire organization can use the report. It can be printed and shared. Delivery in PDF and Excel. Free update of the report after 1 year.

US $ 4499

Need a Discount? Get in touch with us for special pricing

Connect with our sales team